Shares of Aurobindo Pharma on Monday fell nearly 7 per cent to hit fresh 52-week low of Rs 457 on the BSE after the company reported a 41 per cent decline in its consolidated net profit for the second quarter ended September 30, 2022.
The company’s shares plunged 6.52 per cent to its 52-week low of Rs 457.20 on the BSE after a weak beginning.
At the NSE, it declined 6.60 per cent to its 52-week low of Rs 457.
Later, it recovered most of the early lost ground and traded…